Press Releases

Recapitalization Completed and Product Portfolio Expansion

Biocartis Hosts Corporate Workshop and Announces Seven Idylla Abstracts to be Presented at AMP 2023 Annual Meeting

Biocartis Honors Breast Cancer Awareness Month with Launch of Breast Cancer Portfolio

Biocartis Announces Expansion of its Collaboration with APIS Assay Technologies to Commercialize the APIS ESR1 Mutations Kit

Biocartis appoints new Medical Advisory Board (MAB) of renowned practice leaders

Biocartis Partners with Lilly to Explore Biomarker Testing for NSCLC Patients using the Idylla Platform

Biocartis and HiloProbe to Collaborate on Colorectal Cancer Test

Biocartis and APIS Assay Technologies Sign Collaboration to Develop and Commercialise a Breast Cancer Subtyping Test on the Idylla Platform

Biocartis announces the US FDA 510(k) clearance for the Idylla MSI Test

Biocartis announces the launch of the first assay developed with the new Idylla FLEX technology